Bard, Davol Support Centralization Provided all Polypropylene Mesh Products are Included

Bard, Davol Support Centralization Provided all Polypropylene Mesh Products are Included

Introduction

In April, a group of plaintiffs affected by C. R. Bard's hernia mesh products had filed a motion for centralization before the JPML, requesting all Bard polypropylene hernia mesh claims be consolidated for pretrial proceedings in the U.S. District Court for the Southern District of Ohio.

Defendants Bard and Davol have filed a response at court stating they support this decision if all Bard hernia mesh products containing polypropylene, including the Composix Kugel (CK) Hernia Patch complaints that were excluded from their original motion would be included in this MDL.

In addition, the defendants want either New Jersey or southern New York, rather than the Southern District of Ohio as the venue for centralization.

At least 100 hernia mesh lawsuits remain pending in a number of different U.S. District Courts. Each lawsuit raises similar allegations that the defective and unreasonably dangerous design of polypropylene patch products caused plaintiffs to suffer adhesions, infections, recurring hernias, and the need to undergo a revision surgery to remove a hernia patch once they failed.

A hearing is set for May 31 in Chicago or July 26 in Santa Fe, New Mexico, when oral arguments for the motion of consolidation may be scheduled by the JPML.

Atrium C-Qur patch and Ethicon Physiomesh related lawsuits have been centralized as two separate MDLs.